{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-066407","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.350993+00:00","generated_at":"2026-06-04T22:02:36.761119+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Plus Therapeutics CEO presents at JonesResearch webcast; no material new details in filing","bullets":["CEO Marc Hedrick presented at a JonesResearch webcast on March 12, 2024.","Presentation slides filed as Exhibit 99.1 but no specific financial or operational data extracted from filing text.","Slides to be used in upcoming investor meetings as part of Regulation FD disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-066407","json":"https://secwatch.observer/filing/0001193125-24-066407.json","markdown":"https://secwatch.observer/filing/0001193125-24-066407.md","text":"https://secwatch.observer/filing/0001193125-24-066407.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/0001193125-24-066407-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/d804804d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:02:36.761119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}